Stock Updates

Is this Large Market Cap Stock target price reasonable for Bio-Rad Laboratories, Inc. (NYSE:BIO)?

The company in question is, Bio-Rad Laboratories, Inc. (NYSE:BIO) currently with a stock price of 161.39 (0.24% today). The market cap for Bio-Rad Laboratories, Inc. is 4672.51, and is in the sector Healthcare, and Medical Laboratories & Research industry. The target price for Bio-Rad Laboratories, Inc. is 225. Currently Bio-Rad Laboratories, Inc. is trading with a P/E of 48.92, and a forward P/E of 47.36. Average volume for Bio-Rad Laboratories, Inc. is 121.28 and so far today it is 50037.

Performance in the last year for Bio-Rad Laboratories, Inc. has been 18.19%. For EPS growth, Bio-Rad Laboratories, Inc. has seen a growth of 26.10%, and is looking to grow in the next year to 9.68%. More long term stats show that EPS growth has been -10.20% over the last five years and could be 10.00% for the next five years. Bio-Rad Laboratories, Inc. has seen sales growth quarter over quarter at 2.10%, with EPS growth quarter over quarter at -37.10%. The 20-day simple moving average is 2.73%, with the 200-day simple moving average coming to 12.90%.

Since the IPO date for Bio-Rad Laboratories, Inc. on the 2/27/1980, Bio-Rad Laboratories, Inc. has seen performance year to date to be 16.12%. With Bio-Rad Laboratories, Inc. trading at 161.39, the dividend yield is *TBA, and the EPS is 3.29.

So could Bio-Rad Laboratories, Inc., be undervalued? Well as said before P/E is 48.92. The PEG is 4.89, P/S is 2.3 and the P/B is at 1.81. The P/cash is 5.9, with P/free cash flow at 59.75.

Bio-Rad Laboratories, Inc. ability to deal with debt shows that the current ratio is 4.4, and the quick ratio is 3.1. This is with long term debt/equity at 0.17, and total debt/equity at 0.17.

In terms of margins, Bio-Rad Laboratories, Inc. has a gross margin of 55.00%, an operating margin of 6.90% and a profit margin of 4.80%.Payout ratio for Bio-Rad Laboratories, Inc. is 0.00%. Return on assets come to 2.60% with return on investment coming to 4.60%.

Insider ownership for Bio-Rad Laboratories, Inc., is at 2.30% and institutional ownership comes to 77.00%. Outstanding shares are at 29.02. While shares float is 20.98. The float short is currently 6.05%, and short ratio is 10.46.

Disclaimer: Remember there is a risk to your investment, this is not a recommendation, nor personal advice, never invest more than you are able too loose.

About the author

Stephen Butters

Leave a Comment